AMERICAN VANGUARD CORP officer Timothy J. Donnelly received a grant of options covering 20,000 shares of common stock. The options have an exercise price of $2.51 per share and were reported as a direct holding.
These incentive stock options vest in full on the third anniversary of the grant date and expire on the tenth anniversary of the grant date. The grant is categorized as a compensation-related acquisition, with no open-market buying or selling of common shares reported in this filing.
Macicek Steven D reported acquisition or exercise transactions in this Form 4 filing.
American Vanguard Corp director Steven D. Macicek reported an equity award of 31,872 deferred stock units (DSUs) of common stock. The units were granted at no cash cost as part of the company’s compensation program for non‑management directors in connection with the 2026 annual stockholders’ meeting.
Each DSU represents the right to receive one share of common stock upon settlement, which occurs when Macicek’s board service ends, upon a change of control, or upon his death. After this grant, he directly holds 80,711 shares or share-equivalent units. DSUs are nontransferable during service and carry neither voting nor dividend rights until they settle.
American Vanguard Corp director Mark R. Bassett received a grant of 31,872 deferred stock units (DSUs) of common stock as part of the company’s 2026 non-management director compensation program. Following this award, he directly holds 89,919 shares or DSUs in total. Each DSU converts into one common share upon settlement when his board service ends, upon a change of control, or upon his death, and carries no voting or dividend rights while outstanding.
Angelini Marisol reported acquisition or exercise transactions in this Form 4 filing.
American Vanguard Corp director Marisol Angelini received a stock grant. She was awarded 31,872 shares of Common Stock at no cash cost as part of the Company's compensation program for non-management directors in connection with the 2026 annual stockholders' meeting. Following this award, she directly holds 68,762 shares of American Vanguard common stock.
American Vanguard Corp director Patrick E. Gottschalk reported an open-market purchase of 25,000 shares of Common Stock at $2.70 per share. After this transaction, his directly held position increased to 191,705 shares, signaling a larger personal stake in the company.
AMERICAN VANGUARD CORP director Patrick E. Gottschalk bought 40,000 shares of Common Stock in the open market across two days. He purchased 20,000 shares on May 12 at $2.92 per share and 20,000 shares on May 13 at $2.95 per share. Following these transactions, he directly holds 166,705 shares of AMERICAN VANGUARD CORP common stock.
American Vanguard Corporation reported improved but still negative results for the quarter ended March 31, 2026. Net sales rose 7% to $123,568, led by 17% growth in U.S. crop and 6% growth in U.S. Specialty, while International sales fell 7%.
Gross profit increased 27% to $38,417, lifting gross margin to 31% from 26%. Operating expenses grew 6% to $36,528, including $2,804 of transformation costs and $659 of asset impairments tied to restructuring the Los Angeles plant. Net loss narrowed to $4,145 (basic and diluted loss per share of $0.14) from $8,462.
The company refinanced its credit facility with two term loans totaling $285,000, raising total debt (net of discounts and costs) to $266,634 and pushing quarterly interest expense to $5,790 at a 10.9% average rate. New covenants require minimum cash balances and restrict dividends and share repurchases. Management highlights geopolitical risks from war in the Middle East that could pressure growers’ costs and demand.
American Vanguard Corporation is holding its 2026 Annual Meeting of Stockholders virtually on June 3, 2026, at 11:00 a.m. Pacific Time. Stockholders will vote on electing seven directors, ratifying Deloitte & Touche as auditor, setting the frequency of Say‑on‑Pay votes, and approving 2025 executive pay.
The record date is April 10, 2026, with 34,244,580 shares issued and 28,541,878 entitled to vote. The board highlights recent refreshment, a reduced seven‑member size tied to a new term loan, and a majority of independent directors. Executive pay is described as performance‑based, with 2025 bonuses at roughly one‑third of target after flat financial results and no new equity grants.
American Vanguard Corporation reports that three current directors, Scott Baskin, Emer Gunter and Carmen Tiu de Mino, have notified the Board that they will not stand for re-election at the 2026 annual meeting of stockholders. This follows a prior agreement tied to a First Lien Term Loan requiring the Board to shrink from nine to seven members and add one independent director within 90 days following March 13, 2026. The company states that the directors’ decisions are not due to any dispute or disagreement over operations, policies, practices or other matters.
The Vanguard Group amended its Schedule 13G reporting for American Vanguard Corp common stock, stating 0 shares beneficially owned (0%) as of the filing. The amendment attributes the change to an internal realignment on January 12, 2026 under SEC Release No. 34-39538, with subsidiaries reporting separately and pursuing the same investment strategies. The amendment is signed by Ashley Grim on March 26, 2026.